Journal article

Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe

P Villanueva, O Neth, N Ritz, M Tebruegge

European Respiratory Journal | EUROPEAN RESPIRATORY SOC JOURNALS LTD | Published : 2018

Abstract

We read with interest the recent editorial by Cabibbe et al. [1], which highlights the importance of rapid molecular tuberculosis (TB) assays for patient care. Only few paediatric TB experts based in Europe had access to the Xpert MTB/RIF Ultra assay, a new generation molecular TB test, by the end of 2017 http://ow.ly/ZgoF30jHShY

University of Melbourne Researchers

Grants

Funding Acknowledgements

M. Tebruegge reports non-financial support from Cepheid, as he is a co-investigator of a study that will receive support from Cepheid (laboratory materials). The manufacturer was not involved in any aspect of the present study, or the decision to submit the manuscript for publication.